Brian Joseph Cox

Brian Joseph Cox

Auto-generated profile, based on publicly available information

Brian Joseph Cox

Department of Physiology, Department of Obstetrics and Gynaecology, University of Toronto, Toronto, ON, Canada

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 November 2006 in Nature Protocols
Verified
Journal Article
Closed access
PDF file
BCBrian Cox
Brian Cox
AEAndrew Emili
Andrew Emili

1 July 2016 in Hypertension
Verified
Journal Article
Closed access
PDF file
KLKatherine Leavey
Katherine Leavey
SBSamantha J. Benton
Samantha J. Benton
DGDavid Grynspan
David Grynspan
JKJohn C. Kingdom
John C. Kingdom
Shannon A BainbridgeShannon A Bainbridge
Shannon A Bainbridge
BCBrian J. Cox
Brian J. Cox
Preeclampsia (PE) is a complex, hypertensive disorder of pregnancy, demonstrating considerable variability in maternal symptoms and fetal outcomes. Unfortunately, prior research has not accounted for this variability, resulting in a lack of robust biomarkers and effective treatments for PE. Here, we created a large (N=330) clinically relevant human placental microarray data set, consisting of 7 previously published studies and 157 highly annotated new samples from a single BioBank. Applying unsupervised clustering to this combined data set identified 3 clinically significant probable etiologies of PE: “maternal”, with healthy placentas and term deliveries; “canonical”, exhibiting expected clinical, ontological, and histopathologic features of PE; and “immunologic” with severe fetal growth restriction and evidence of maternal antifetal rejection. Moreover, these groups could be distinguished using a small quantitative polymerase chain reaction panel and demonstrated varying influence of maternal factors on PE development. An additional subclass of PE placentas was also revealed to form because of chromosomal abnormalities in these samples, supported by array-based comparative genomic hybridization analysis. Overall, our findings represent a new paradigm in our understanding of the origins and maternal–placental contributions to the pathology of PE. The study of PE represents a unique opportunity to access human tissue associated with a complex hypertensive disorder, and our novel approach could be applied to other hypertensive and heterogeneous human diseases.

1 December 2018 in American Journal of Obstetrics and Gynecology
Verified
Journal Article
Closed access
SBSamantha J. Benton
Samantha J. Benton
KLKatherine Leavey
Katherine Leavey
DGDavid Grynspan
David Grynspan
BCBrian J. Cox
Brian J. Cox
Shannon A BainbridgeShannon A Bainbridge
Shannon A Bainbridge

16 June 2009 in Molecular Systems Biology
Verified
Journal Article
Open access
PDF file
BCBrian Cox
Brian Cox
MKMax Kotlyar
Max Kotlyar
AEAndreas I Evangelou
Andreas I Evangelou
VIVladimir Ignatchenko
Vladimir Ignatchenko
AIAlex Ignatchenko
Alex Ignatchenko
TKThomas Kislinger
Thomas Kislinger
Placental abnormalities are associated with two of the most common and serious complications of human pregnancy, maternal preeclampsia (PE) and fetal intrauterine growth restriction (IUGR), each disorder affecting ∼5% of all pregnancies. An important question for the use of the mouse as a model for studying human disease is the degree of functional conservation of genetic control pathways from human to mouse. The human and mouse placenta show structural similarities, but there have been no systematic attempts to assess their molecular similarities or differences. We collected protein and mRNA expression data through shot‐gun proteomics and microarray expression analysis of the highly vascular exchange region, microdissected from the human and mouse near‐term placenta. Over 7000 ortholog genes were detected with 70% co‐expressed in both species. Close to 90% agreement was found between our human proteomic results and 1649 genes assayed by immunohistochemistry for expression in the human placenta in the Human Protein Atlas. Interestingly, over 80% of genes known to cause placental phenotypes in mouse are co‐expressed in human. Several of these phenotype‐associated proteins form a tight protein–protein interaction network involving 15 known and 34 novel candidate proteins also likely important in placental structure and/or function. The entire data are available as a web‐accessible database to guide the informed development of mouse models to study human disease. ### Synopsis The modeling of human disease in mouse has had success, but there have also been many failures. A priori , it is unclear if mutation of the orthologous gene in mouse will recapitulate the human phenotype. Although, many large‐scale datasets for microarray and proteomics exist for both mouse and human, they are rarely integrated and compared. To better predict if mutation in a mouse gene will give the equivalent phenotype as the human ortholog, a detailed molecular understanding of the orthologous/homologous tissues from human and mouse are needed. By using a dataset of ortholog gene and protein expression, comparisons can be made as to the conservation of protein interaction networks and regarding the co‐expression of phenotype‐associated proteins. One organ that can be obtained from non‐pathological human samples is the placenta. This organ is also the source of the primary defect in two of the most prevalent diseases of pregnancy, intrauterine growth restriction (IUGR) and preeclampsia (PE). Although the placentas of no two mammalian species are the same, the placentas of humans and mice have strong similarities. In both species, maternal blood from the uterine arteries enters the placenta from large diameter, spiral arteries located in the maternal decidua. The maternal blood then percolates through a dense mesh of channels created and lined by fetal trophoblast cells in which an equally dense network of fetal capillaries is localized. This region is the site of feto‐maternal exchange and is called the villous tree in humans and the labyrinth in mice. In both species, the umbilical vessels connect the fetal capillaries of the placental exchange region with the fetal body circulation. IUGR and PE, which combined affect ∼5% of all pregnancies are both associated with serious morbidity and mortality, and the only known treatment is premature delivery, which places the baby at high risk of prematurity‐related complications. Although, PE and IUGR have been intensely studied for decades, the molecular pathways, etiology and pathogenesis of these diseases remain poorly understood. Our aim was to empirically determine the molecular similarity of these two vascular exchange regions based on subcellular proteomics and transcriptional profiling, to assess the compatibility of mouse placenta to model human placenta biology. Our proteomic analysis was validated by comparison to both matched mRNA samples analyzed by microarray and to 4872 proteins assayed by immunohistochemistry (IHC) on human placenta samples in the Human Protein Atlas ([www.proteinatlas.org][1]). In both cases high correlation was found between the protein to microarray (⩾95%) and protein to IHC ⩾90%. Of key interest was the degree of molecular similarity between the mouse and human vascular exchange regions of the placenta. Data for observed proteins and their corresponding microarray probe sets were paired for human and mouse placenta samples. These protein/probe pairs were then linked between the two species using orthology data form ENSEMBL. This dataset of orthologous proteins/probes was then clustered to identify genes with common expression. This could be further classified into three categories. In all cases microarray data showed expression in both species, and protein data were observed in both species (cluster I), one species (cluster II) or in neither species (cluster III) ([Figure 2A][2]). Organellar localization associated with significant enrichment for appropriate Gene Ontology annotation terms was observed for cluster I proteins ([Figure 2B][2]). Interestingly, organellar localization showed striking agreement for co‐expressed ortholog proteins in cluster I ([Figure 2A and C][2]) as predicted by Pearson correlation, which argues for functional conservation for most ortholog proteins. Overall our analysis revealed ∼70% conserved expression of one‐to‐one ortholog genes between mouse and human placental exchange regions. We made similar comparison of microarray data deposited at the GEO repository, for other matched tissues. We found similar levels of conservation for matched tissues and lower levels against all other tissues. We next compared the level of conservation of genes that when mutant in the mouse give placenta phenotypes. We found an even higher conservation of expression of these phenotypic genes between...

13 February 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
KLKatherine Leavey
Katherine Leavey
Shannon A BainbridgeShannon A Bainbridge
Shannon A Bainbridge
BCBrian J Cox
Brian J Cox
Preeclampsia (PE) is a life-threatening hypertensive pathology of pregnancy affecting 3–5% of all pregnancies. To date, PE has no cure, early detection markers, or effective treatments short of the removal of what is thought to be the causative organ, the placenta, which may necessitate a preterm delivery. Additionally, numerous small placental microarray studies attempting to identify “PE-specific” genes have yielded inconsistent results. We therefore hypothesize that preeclampsia is a multifactorial disease encompassing several pathology subclasses, and that large cohort placental gene expression analysis will reveal these groups. To address our hypothesis, we utilized known bioinformatic methods to aggregate 7 microarray data sets across multiple platforms in order to generate a large data set of 173 patient samples, including 77 with preeclampsia. Unsupervised clustering of these patient samples revealed three distinct molecular subclasses of PE. This included a “canonical” PE subclass demonstrating elevated expression of known PE markers and genes associated with poor oxygenation and increased secretion, as well as two other subclasses potentially representing a poor maternal response to pregnancy and an immunological presentation of preeclampsia. Our analysis sheds new light on the heterogeneity of PE patients, and offers up additional avenues for future investigation. Hopefully, our subclassification of preeclampsia based on molecular diversity will finally lead to the development of robust diagnostics and patient-based treatments for this disorder.

2 March 2018 in Clinical Epigenetics
Verified
Journal Article
Open access
PDF file
KLKatherine Leavey
Katherine Leavey
SWSamantha L. Wilson
Samantha L. Wilson
Shannon A BainbridgeShannon A Bainbridge
Shannon A Bainbridge
WRWendy Robinson
Wendy Robinson
BCBrian J. Cox
Brian J. Cox
Preeclampsia (PE) is a heterogeneous, hypertensive disorder of pregnancy, with no robust biomarkers or effective treatments. We hypothesized that this heterogeneity is due to the existence of multiple subtypes of PE and, in support of this hypothesis, we recently identified five clusters of placentas within a large gene expression microarray dataset (N = 330), of which four (clusters 1, 2, 3, and 5) contained a substantial number of PE samples. However, while transcriptional analysis of placentas can subtype patients, we propose that the addition of epigenetic information could discern gene regulatory mechanisms behind the distinct PE pathologies, as well as identify clinically useful potential biomarkers. We subjected 48 of our samples from transcriptional clusters 1, 2, 3, and 5 to Infinium HumanMethylation450 arrays. Samples belonging to transcriptional clusters 1–3 still showed visible relationships to each other by methylation, but cluster 5, with known chromosomal abnormalities, no longer formed a cohesive group. Within transcriptional clusters 2 and 3, controlling for fetal sex and gestational age in the identification of differentially methylated sites, compared to the healthier cluster 1, dramatically reduced the number of significant sites, but increased the percentage that demonstrated a strong linear correlation with gene expression (from 5% and 2% to 9% and 8%, respectively). Locations exhibiting a positive relationship between methylation and gene expression were most frequently found in CpG open sea enhancer regions within the gene body, while those with a significant negative correlation were often annotated to the promoter in a CpG shore region. Integrated transcriptome and epigenome analysis revealed modifications in TGF-beta signaling, cell adhesion, oxidative phosphorylation, and metabolism pathways in cluster 2 placentas, and aberrations in antigen presentation, allograft rejection, and cytokine-cytokine receptor interaction in cluster 3 samples. Overall, we have established DNA methylation alterations underlying a portion of the transcriptional development of “canonical” PE in cluster 2 and “immunological” PE in cluster 3. However, a significant number of the observed methylation changes were not associated with corresponding changes in gene expression, and vice versa, indicating that alternate methods of gene regulation will need to be explored to fully comprehend these PE subtypes.